FNY Managed Accounts’s West Pharmaceutical WST Stock Holding History

FNY Managed Accounts’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-34	Closed	-$3K	–	868
2017 Q4	$3K	Buy	+34	New	+$3.33K	﹤0.01%	472

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

FNY Managed Accounts's WST Position: Q1 2018 in Review

FNY Managed Accounts sold out of West Pharmaceutical (WST) in Q1 2018, closing a stake of 34 shares — an estimated $3K sold.

FNY Managed Accounts first reported a position in WST in Q4 2017 and held it in 1 quarter. The position peaked at $3K in Q4 2017. 323 funds tracked by Wall St. Rank hold WST as of Q1 2018.

FNY Managed Accounts reported no remaining West Pharmaceutical position as of Q1 2018 after selling out during the quarter.
FNY Managed Accounts sold 34 West Pharmaceutical shares in Q1 2018, an estimated $3K.
FNY Managed Accounts first reported a position in West Pharmaceutical in Q4 2017 and held it in 1 quarter.
FNY Managed Accounts's West Pharmaceutical position peaked at $3K in Q4 2017.
323 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.